Use of antisense oligodeoxynucleotede to determine δ-opioid receptor involvement in [D-Ala2]deltorphin ii-induced locomotor hyperactivity

Life Sciences

Volumn 59, Issue 4, 1996, Pages

  Mizoguchi, Hirokazu ^a   Narita, Minoru ^a   Nagase, Hiroshi ^b   Suzuki, Tsutomu ^c   Quock, Raymond M ^d   Tseng, Leon F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b TORAY INDUSTRIES INC   (Japan)

^c HOSHI UNIVERSITY   (Japan)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

antisense oligo and locomotor hyperactivity

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DELTORPHIN; NALTRIBEN; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; DRUG RECEPTOR BINDING; HYPERACTIVITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; RAT;

AMINO ACID SEQUENCE; ANALYSIS OF VARIANCE; ANIMALS; BASE SEQUENCE; BENZYLIDENE COMPOUNDS; CEREBRAL VENTRICLES; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; MOTOR ACTIVITY; NALTREXONE; NARCOTIC ANTAGONISTS; OLIGONUCLEOTIDES, ANTISENSE; OLIGOPEPTIDES; RECEPTORS, OPIOID, DELTA; SOMATOSTATIN; THIONUCLEOTIDES;

EID: 0030016488     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00307-4     Document Type: Article

References (15)

1. C. WAHLESTEDT, Trends Pharmacol. Sci. 15 42-46 (1994).
2. C. WAHLESTEDT, E.M. PICH, G.F. KOOB, F. YEE and M. HEILIG, Science 259 528-531 (1993).
3. G.W. PASTERNAK and K.M. STANDIFER, Trends Pharmacol. Sci. 16 344-350 (1995).
4. G. ROSSI, Y.X. PAN, J. CHENG and G.W. PASTERNAK, Life Sci. 54 PL375-379 (1994).
5. K.M. STANDIFER, C.C. CHIEN, C. WAHLESTEDT, G.P. BROWN and G.W. PASTERNAK, Neuron 12 805-810 (1994)
6. J.U. ADAMS, X. CHEN, J.K. DERIEL, M.W. ADLER and L.Y. LIU-CHEN, Brain Res. 667 129-132 (1994).
7. L.F. TSENG, K.A. COLLINS, M. NARITA and J.P. KAMPINE, Analgesia 1 121-126 (1995).
8. L.F. TSENG, K.A. COLLINS and J.P. KAMPINE, Eur. J. Pharmacol. 258 R1-R3 (1994).
9. H.Q. WANG, J.P. KAMPINE and L.F. TSENG, Neuroscience (in press).
10. C.J. EVANS, D.E. KEITH, H. MORRISON, K. MAGENDZO and R.H. EDWARDS, Science 258 1952-1955 (1992).
11. M.J. HALEY and W.G. MCCORMICK, Br. J. Pharmacol. 12 12-15 (1957).
12. L. NEGRI, V. NOVIELLO and F. ANGELUCCI, Eur. J. Pharmacol. 209 163-168 (1991)
13. M. UKAI, T. TOYOSHI, M. MIZUTANI, Y. SAKAKI and T. KAMEYAMA, Jpn. J. Psychopharmacol. 14 161-168 (1994).
14. X.H. CHEN, E.B. GELLER, J.K. DERIEL, L.Y. LIU-CHEN and M.W. ADLER, Brain Res. 688 237-241 (1995).
15. X.H. CHEN, J.U. ADAMS, E.B. GELLER, J.K. DERIEL, M.W. ADLER and L.Y. LIU-CHEN, Eur. J. Pharmacol. 275 105-108 (1995)